CEO: Cedric Francois

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.


Key numbers

Market Capitalization:1756281120
Shares Outstanding: 63888000
Float: 46777579.728
Next Earning Date:2020-03-23
TTm EPS: -3.7406
TTm Dividend Rate:
200 days moving average:23.14
50 days moving average: 27.16
One day percent Change: 4.4



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,